Financials

  • Market Capitalization 351.79 M
  • Employee 533
  • Founded 2002
  • CEO N/A
  • Website www.vandapharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000HT5MG6
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.36
Fiyat/satışlar oranı
2.41

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
3142
AVIR
Atea Pharmaceuticals, Inc. - common stock
4.70 USD-0.84%-2.69%+6.82%+46.42%376.13 M USD
3174
LXEO
Lexeo Therapeutics, Inc. - Common Stock
4.62 USD-0.65%-3.95%-2.12%+11.06%362.77 M USD
3199
GALT
Galectin Therapeutics Inc. - Common Stock
5.34 USD+16.09%+18.40%+103.82%+90.71%351.68 M USD
3206
PRLD
Prelude Therapeutics Incorporated - Common Stock
4.39 USD-1.13%-11.49%+0.46%+441.98%349.64 M USD

Haberler